chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Arm began to ache ~7pm, increasing until ~12am. Fever began ~9pm, increasing until ~1am. Fatigue began ~10:20pm, increasing until ~12am. Chills began ~12:30am, increasing until ~2am. Went to sleep ~2am. No medication. Disrupted sleep; slept ~60-120 minutes at a time: 2:15-4:20, 5:10-7:10, 7:30-8:10, 8:45-9:40, 10:15-11:40. Next day, woke with full-body aches (ongoing, declining slowly in severity), chills gone, fever remaining (ongoing, declining slowly), pounding headache especially upon rising/moving around (ongoing). Lymph nodes swollen in right underarm, collarbone, and neck (ongoing). Took 600mg ibuprofen afternoon 4/8; helped with aches. Took 2 Zzquil ~1am to help with sleep; slept through the night and woke ~8:20am. Napped again ~9am-12pm. Took 600mg ibuprofen upon rising. Remaining symptoms: full-body aches (especially right arm and torso), headache, swollen lymph nodes, mild fatigue.
Patient tested positive for COVID 4/5/2021.  Symptom onset 4/2/21.  Pt had exposure to COVID positive individual. Symptoms were sore throat and runny nose.
Red, hot to touch, swelling around upper arm, hardened bump on Lt upper arm, very painful, hurts to touch, hurts to move arm, using ice packs. Reaction started the next day 12/3/15.
IGA vasculitis; This is a spontaneous report from a contactable consumer. This consumer (patient's father) reported for a 40-year-old male patient (reporter's son).  A 40-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection; Batch/Lot number: unknown, Expire Date: Unknown), via an unspecified route of administration on Apr2021 (at the age of 40-year-old) as dose 1, single for COVID-19 immunization. Patient's concomitant medications were not reported. Patient's report was not related to a study or Programme. Patient had no history of previous immunization with the Pfizer vaccine considered as suspect. Patient had no additional Vaccines administered on same date of the Pfizer Suspect. Patient had no adverse event following prior vaccinations. Caller stated a year ago from Apr2021, so about 18 months ago, his son had what they all thought may have been Covid, but he could not get a test and he went to the hospital a couple of times, but they still never tested him for Covid, that was when tests were hard to get. Caller stated the doctors now were suggesting he might have had Covid last Apr2021. Caller stated they are saying he probably did have it. The patient experienced IGA vasculitis on 25Apr2021. It was reported that the patient got his first dose of the Pfizer BioNTech Covid-19 vaccine in Apr2021. Within 6 days, he got IGA vasculitis and was told not to get the second dose because of the vasculitis. Caller stated it went undiagnosed for a good couple of weeks. Caller stated this was back in Apr2021, and it had not gone away yet, it was better, but had not gone away. He was asking if there was any relation between vasculitis and the vaccine. Caller felt like the question of whether or not to get the second dose should had been asked by his son's doctors back in May2021 when he was finally diagnosed, which took a long time. His concern was that his son and his wife have a 2-week-old infant, and he was walking around with only one dose of the vaccine, so he was concerned about his son, his wife, and the baby. He had not received the second dose, greater than 21 days. Caller states 2 weeks ago, him and his wife had a baby. Caller stated so now his son was caring for his newborn grandchild, and he was only half vaccine. Caller stated his son sent him a picture of his leg on 01May2021, and it is hard to look at. Caller stated so this happened in Apr2021. Caller stated the injection was in the first or second week of Apr2021. Patient received Prednisone for the treatment of event. The outcome of the event was resolving.  The lot number for BNT162b2, was not provided and will be requested during follow up.
rash around mouth by morning had spread to entire body;rash red, flat, sl raised, non pruritic;no fever, no cough;+ blanching;
The patient came into the clinic and requested the Johnson and Johnson vaccine and was given the Pfizer Vaccine.
vaccine given 6 days post expiry; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccine given 6 days post expiry) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccine given 6 days post expiry). On 12-Nov-2021, EXPIRED PRODUCT ADMINISTERED (vaccine given 6 days post expiry) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was given.  No treatment medication was given.  No adverse event reported.   This case was linked to MOD-2021-395985 (Patient Link).
Patient had a fainting episode with with no other complications. Patient was sitting and no fall occured. Patient woke up after approximatly 5 seconds. Patient was advised to keep sitting and was given Gatorade to rehydrate. Patient had not eaten prior to vaccine.
I got Moderna arm for two weeks.  I finally had to take Zyrtec for the hives to go away.    I had a fever for about 50 hours after the 2nd vaccine.
Went ER after 2 episode of some "twitching" and syncope per wife's report. Evaluated by cardiology and hospitalized
2nd dose received greater than 36 days from the 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose received greater than 36 days from the 1st dose) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038K20A and 026L20A) for COVID-19 vaccination.     Concurrent medical conditions included Pollen allergy.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose received greater than 36 days from the 1st dose). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose received greater than 36 days from the 1st dose) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Other concomitant included Blood pressure medication. Reporter reported that patient had not received any treatment.   This case was linked to MOD-2022-584523 (Patient Link).
Left thigh red area 4x1 3/4 inch.  Gave Keflex by MD.
Patient called two days later saying her arm swelled up from shoulder to elbow. Next day didn't go down at all. Sunday 10/15/17 she woke up in the morning and both eyes swollen and rash on arms, as well as face. She saw Dermatologist who prescribed Triamcinolone and Hydrocortisone cream for rash area. I talked with the clinician and she didn't know if it was the vaccine but felt I should submit this form. Patient has had the FLUZONE for the last 3 years here at our pharmacy with no problems ever.
Hard knot at injection site has continued to get larger and is now the size of the palm of my hand and is hot to the touch.
This spontaneous report was received from a registered nurse refers to an unspecified number of patients of unknown age. On an unknown date, the patients were vaccinated with improperly stored doses of VARIVAX (Merck) (Lot L006384 expiry 25-FEB-2017), (Lot K002918 expiry 26-FEB-2016). No adverse event was reported. This is one of the two reports received from the same reporter. Additional information has been requested.
Post vax, the patient experienced a local reaction of her left upper arm. The patient's upper arm was hot, red and swollen. The patient was treated wtih Z-pak and Zyrtec.
no additional AE; received improperly stored vaccine.; This spontaneous report was received from a healthcare worker, referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not provided.  On 17-AUG-2023, the patient received one dose of improperly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live (recombinant human albumin (rHA)) (PROQUAD) injection (lot #was reported as x009733, but established as X009733 per company guidelines, expiration date: 02-SEP-2024; strength and route were unknown) administered for prophylaxis.  Temperature excursion of this vaccine was 29 Fahrenheit degrees for 4 hours and 30 minutes. There was no previous temperature excursion. No additional adverse event was reported.
sick for a day; Caller stated she is worried that her daughter may have not gotten the correct vaccine.; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the parent.  A 18 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "Allergies" (unspecified if ongoing). The patient's concomitant medications were not reported.  The following information was reported: ILLNESS (non-serious), outcome "unknown", described as "sick for a day"; CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (non-serious), outcome "unknown", described as "Caller stated she is worried that her daughter may have not gotten the correct vaccine.".  Additional information: Caller stated she is really confused about the approval of the Pfizer covid vaccine. Her 18 years old daughter received the first dose and was sick for a day. She has allergy and does not take flu vaccine due to her allergies. Caller stated she is worried that her daughter may have not gotten the correct vaccine. She has to take it to attend her collage. she is worried that her daughter may not be the candidate for this vaccine and may experience bad reaction. She queried is it COMIRNATY that is out there or Pfizer covid vaccine that people are getting.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea) in an 84-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029m02a) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (Diarrhea). At the time of the report, DIARRHOEA (Diarrhea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment details were not provided.
Diffuse erythema, vomiting, hypothermia, wheezing, anaphylaxis concerning.
Noticed pulse of 35 - asympotmatic - no sycope or dizziness.  Able to exercise to a pulse of 180 but always returns to the 30s.
The patient became scared about getting the second dose due to the media and never received her second administration of the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of INTENTIONAL PRODUCT USE ISSUE (The patient became scared about getting the second dose due to the media and never received her second administration of the vaccine) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008B21A) for COVID-19 vaccination.     Concurrent medical conditions included Heart disease, unspecified (She does have a history of heart problems, recently visited her cardiologist). Concomitant products included CARVEDILOL, PRAVASTATIN, EZETIMIBE, SPIRONOLACTONE, ATORVASTATIN and ASPIRIN [ACETYLSALICYLIC ACID] for an unknown indication.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced INTENTIONAL PRODUCT USE ISSUE (The patient became scared about getting the second dose due to the media and never received her second administration of the vaccine). On 24-Mar-2021, INTENTIONAL PRODUCT USE ISSUE (The patient became scared about getting the second dose due to the media and never received her second administration of the vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient reported that she did not had any side effects following the vaccine.
Severe stomach pain, ER visit, CT scan identifying Perforated Appendicitis, leading to appendectomy and 4 days in hospital with JP drain tube in place at discharge until 6 days later.  Of interest, brother had mRNA vaccine 3-4 weeks  earlier and also ended up with appendicitis requiring appendectomy in 2nd week after second vaccine dose.
Patient experienced  several blister appear on 05/13/19 after receiving shingrix and boostrix on 05/10/19.  Md dignosied patient with shingles on 05/15/ and prescribed Valtrex  for treatment.
Muscle pain; Chills; Nausea; This is a spontaneous report from a contactable consumer. A 60-year-old female patient received the first dose of  bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date were not reported), via an unspecified route of administration in left upper arm on 11Jan2021 around 3:45-4:00pm at a single dose for COVID-19 vaccination. Medical history included hypothyroidism. Concomitant medication included levothyroxine from 2006 for hypothyroidism. The patient was administered the first dose of Pfizer-BioNTech COVID Vaccine on 11Jan2021 at work. On 12Jan2021, the patient experienced muscle pain, chills, nausea. The outcome of the events was not recovered. The patient underwent rapid COVID-19 nasal swab test and the result was negative on 12Jan2021. Second dose scheduled to be administered on 01Feb2021 with no dose change made.  Information on the Lot/batch number has been requested.
Hair loss after receiving the Moderna vaccine; This spontaneous case was reported by a consumer and describes the occurrence of ALOPECIA (Hair loss after receiving the Moderna vaccine) in a female patient of an unknown age who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ALOPECIA (Hair loss after receiving the Moderna vaccine). At the time of the report, ALOPECIA (Hair loss after receiving the Moderna vaccine) outcome was unknown.      The action taken with mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) was unknown.   No concomitant medication information was provided. No treatment medication were provided.   This case was linked to US-MODERNATX, INC.-MOD-2022-670176, US-MODERNATX, INC.-MOD-2022-670184 (E2B Linked Report).   Reporter did not allow further contact; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-670184:Male case 1 US-MODERNATX, INC.-MOD-2022-670176:Female case 1
Patient was fine all day until 5pm. Shaking, chills, vomiting, chest pains, cold sweats, fever of 101 degrees, chest pain, light headed, tired, no appetite. ER could not find a cause, other than the flu shot received.
Headache, low grade fever, chills, muscle aches, occasional cough, nausea
pt states that he about an hour after taking the vax he had slight pain at the injection site and headache.  He started getting dizzy and lightheaded.  Pt took 1000mg Tylenol for his head ache.
After dose 1, I became lethargic and dizzy. I left work and went home. I had a headache, nausea, stomach pains and diarrhea for 4 days. I missed a day of work. The injections site was red, hot, itchy and sore. It bruised and stayed that was for 3 weeks.  After the 2nd dose, I became ill within an hour of receiving the vaccine. I left work early b/c I was dizzy, lethargic and had a bad headache. I missed work the next day b/c I had a fever of 102, chills, vomiting, diarrhea, body aches, dizziness and a headache. I stayed in bed all day and drank water and took Tylenol. By 6pm, my temp was finally down to 99.0. For the next 3 days, I have had diarrhea. The injection site bled alot this time but surprisingly, its not as sore as the first. It is red and slightly painful.
not feeling well; This is a spontaneous report from a contactable consumer. A male patient of unknown age received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 13Apr2021 as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, it was unknown whether the patient was diagnosed with COVID-19. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. It was unknown whether the patient receive any other vaccines within four weeks prior to the vaccination. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. On 14Apr2021, the patient experienced not feeling well after his second dose. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. It was unknown whether any therapeutic measures were taken as a result of the event. The clinical outcome of the event not feeling well was not recovered at the time of this report.    No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
some itchiness and swelling to her left eyelid and the area immediately around it.  She also felt a little numbness in this patch of skin around the area.  these all resolved with cetirizine. She reports a reduction in  left visual acuity today (4/29/21) since the vaccine that  did not go away and resulted in her needing to get a new prescription for glasses.  there urgent care note from 01/31/2021 remarks "no vision changes"
Patient came in on saturday 2-9-19 to complain of a rash that had developed all over her body. In addition to the rash, patient complained about swollen or inflammed arms and leg plus warm to the touch, itchy feet. Stated that she took benadryl and it calmed down. The rash on her hands were barely noticeable but she was wearing long sleeve so couldnt see the rash around the injection site that was still present.  I explained to her that its a side effect but that if it didnt go away in a few days then she might have to see her PCP.
1/19/10 Mother called stated the child was cranky and fussy. She asked if she could get a excuse for work because she could not go to work.
A HCP called and reported an AE where an adult patient received a dose of PROQUAD inadvertently on an unknown date.; No additional adverse event reported; This spontaneous report was received from a register nurse and refers to an adult patient of unknown age. No information regarding the patient's medical history, concurrent conditions, previous drug reactions or allergies and concomitant medications was provided.  On an unknown date, the patient was vaccinated inadvertently with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (strength, dose description, lot #, expiry date, and route of administration were not provided) (product administered to patient of inappropriate age). No additional adverse event was provided.
immed fussy w/erythema 8-10cm & tenderness which responded to ice; temp 101.8; treated w/APAP; calling to find out if this is contraindication to next pertussis;
Information has been received from a physician concerning a 16 year old female patient who on 28 Aug 2006 was vaccinated with a first dose of Gardisil. On 28 Aug 2006 the patient experienced vomiting within four hours of receiving the vaccination. Outcome was not reported. On 25 Oct 2006, the patient was vaccinated with a second dose of Gardisil. On 25 Oct 2006 the patient experienced vomiting within four hours of receiving the vaccination. On 25 Oct 2006, the patient recovered from vomiting. Additional information has been requested. Initial and follow-up information has been received from a physician and a licensed practical nurse concerning a 16 year old female patient who on 28-AUG-2006 was vaccinated with a first dose of GARDASIL 0.5 ml IM.  On 28-AUG-2006, the patient experienced vomiting within four hours of receivng the vaccination.  The patient recovered on 28-AUG-2006.  On 25-OCT-2006, the patient was vaccinated with a second dose of GARDASIL 0.5 ml IM.  On 25-OCT-2006 the patient experienced vomiting within four hours of receiving the vaccination.  The mother felt that the vomiting was flu related for the first dose, however the vomiting happened again after the second dose.  The patient recovered on 25-OCT-2006.  No additional information is expected.
Patient presented on 12/16/21 to the phamacist on duty and complained that their arm was still sore at site of injection on the right deltoid. He also said it is difficult to lift things due to the discomfort.
Local area swelling L deltoid 2-3 hours post inj: generalized pruritus, L axillary soreness. Local tenderness, swelling at site, itching.
PATIENT SAID HE HAS GOTTEN DIZZY IN PAST AFTER GETTING VACCINATIONS BUT 1ST COVID VACCINE WENT WELL.  I TOLD PATIENT TO STAY 30 MINUTES TO ENSURE HE DID NOT HAVE ANY TYPE OF REACTION.  PATIENT SAT IN FRONT OF PHARMACY. PATIENT SITTING IN CHAIR AND FAINTED. FELL TO FLOOR, DAID HE HIT HIS HEAD, INSIDE OF LIP BLED. MOM IS NURS PRACTITIONER, SAID SHE HAD TO LEAVE HIM TO GO TO DOWNSTAIRS BATHROOM OTHERWISE SHE WOULD HAVE BEEN WITH HIM.  I SAW MOM WAS WITH HIM BEFORE AND AFTER VACCINATION BUT DID NOT SEE HER LEAVE TO GO TO BATHROOM.
administered PROQUAD and VARIVAX at the same visit; No adverse effetcs reported; This spontaneous report was received from a nurse regarding a patient of an unknown age and gender. The patient's concurrent conditions, medical history, concomitant therapy and drug allergies were not reported. On an unknown date, the patient was vaccinated with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) (lot number: R002938, expiration date: 29-JUL-2019)for prophylaxis which was reconstituted with sterile diluent (lot number: N030179, expiration date: 03-JUL-2020). On the same day at the same visit, the patient was vaccinated with varicella virus vaccine live (Oka/Merck)(VARIVAX) (lot number: N034557, expiration date: 05-DEC-2019) for prophylaxis which was reconstituted with sterile diluent (lot number: N006324, expiration date: 24-JUL-2019)(Inappropriate schedule of product administration). No adverse events were reported. No product quality complaint involved.